难治性强迫症脑深部电刺激前瞻性国际多中心安全性与疗效研究
该前瞻性开放标签国际多中心研究纳入30例双侧内囊前肢植入DBS电极的难治性强迫症患者,随访12个月。所有患者均出现不良事件(共195次),多数为轻度(52%)或中度(37%),严重不良事件共36次。12个月时Y-BOCS评分降低42%,应答率60%,GAF、CGI及EuroQol-5D指数亦有改善。
要点
- 所有患者均出现不良事件,多数为轻度或中度且短暂,中位缓解时间22天。
- 不良事件最常见病因为编程/刺激相关(26例),严重不良事件主要为短暂焦虑和情感症状加重。
- 12个月时Y-BOCS评分降低42%,应答率60%,功能与生活质量评分亦改善。
核心结论
- 在严重难治性强迫症人群中,开放标签研究支持DBS的潜在获益大于潜在风险。
研究设计与样本
- 前瞻性、开放标签、干预性国际多中心研究,纳入30例双侧内囊前肢植入DBS电极的难治性强迫症患者。
主要发现
- 所有患者共报告195次不良事件,其中52%为轻度、37%为中度,中位缓解时间22天。
- 不良事件病因中最常见为编程/刺激相关(26例),其次为新发疾病/损伤/状况(13例)和原有疾病恶化(11例)。
- 12个月时Y-BOCS评分降低42%,应答率60%,GAF、CGI和EuroQol-5D指数评分亦有改善。
关键数值与推荐
- 不良事件按EN ISO14155:2011由独立临床事件委员会分类和编码。
- 疗效评估在植入后3、6、12个月进行,12个月时Y-BOCS降低42%、应答率60%。
临床怎么用
- 对于严重难治性强迫症患者,DBS可作为潜在治疗选择,但需监测编程/刺激相关不良事件并及时调整刺激参数。
局限性
- 开放标签设计可能引入偏倚,样本量较小(30例),缺乏盲法对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventional multi-center study, we examined the safety and efficacy of electrical stimulation in 30 patients with DBS electrodes bilaterally implanted in the anterior limb of the internal capsule. Safety, efficacy, and functionality assessments were performed at 3, 6, and 12 months post implant. An independent Clinical Events Committee classified and coded all adverse events (AEs) according to EN ISO14155:2011. All patients experienced AEs (195 in total), with the majority of these being mild (52% of all AEs) or moderate (37%). Median time to resolution was 22 days for all AEs and the etiology with the highest AE incidence was 'programming/stimulation' (in 26 patients), followed by 'New illness, injury, condition' (13 patients) and 'pre-existing condition, worsening or exacerbation' (11 patients). Sixteen patients reported a total of 36 serious AEs (eight of them in one single patient), mainly transient anxiety and affective symptoms worsening (20 SAEs). Regarding efficacy measures, Y-BOCS reduction was 42% at 12 months and the responder rate was 60%. Improvements in GAF, CGI, and EuroQol-5D index scores were also observed. In sum, although some severe AEs occurred, most AEs were mild or moderate, transient and related to programming/stimulation and tended to resolve by adjustment of stimulation. In a severely treatment-resistant population, this open-label study supports that the potential benefits outweigh the potential risks of DBS.
引用
- Menchón JM, Real E, Alonso P, et al. A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. Mol Psychiatry. 2019. PMID: 31664175. doi:10.1038/s41380-019-0562-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。